Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Swiss biotech Oculis raises cash, nabs Novartis eye drug in extended series B

fiercebiotechJanuary 07, 2019

Tag: eye treatments , Oculis , Novartis , LME636

PharmaSources Customer Service